Design, synthesis, and biological evaluation of novel 1-aryl-3-hydroxypyrrolidine derivatives as dual HGK/HPK1 inhibitors with therapeutic potential for lung cancer.
- DOI
- 10.1016/j.bioorg.2026.110473
- Published
- 2026 Sep 6
- Container
- Bioorganic chemistry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bioorg.2026.110473,
title = {Design, synthesis, and biological evaluation of novel 1-aryl-3-hydroxypyrrolidine derivatives as dual HGK/HPK1 inhibitors with therapeutic potential for lung cancer.},
author = {Liu S and Ma J and Li Y and Yang J and Zhang D and Cai N and Tan Z and Zhai X},
year = {2026},
journal = {Bioorganic chemistry},
doi = {10.1016/j.bioorg.2026.110473},
url = {https://doi.org/10.1016/j.bioorg.2026.110473}
}RIS
TY - JOUR TI - Design, synthesis, and biological evaluation of novel 1-aryl-3-hydroxypyrrolidine derivatives as dual HGK/HPK1 inhibitors with therapeutic potential for lung cancer. AU - Liu S AU - Ma J AU - Li Y AU - Yang J AU - Zhang D AU - Cai N AU - Tan Z AU - Zhai X PY - 2026 JO - Bioorganic chemistry DO - 10.1016/j.bioorg.2026.110473 UR - https://doi.org/10.1016/j.bioorg.2026.110473 ER -
APA
S, L., J, M., Y, L., J, Y., D, Z., N, C., Z, T., & X, Z. (2026). Design, synthesis, and biological evaluation of novel 1-aryl-3-hydroxypyrrolidine derivatives as dual HGK/HPK1 inhibitors with therapeutic potential for lung cancer.. Bioorganic chemistry. https://doi.org/10.1016/j.bioorg.2026.110473
Source records
- pubmed · retrieved 2026-09-27T00:19:11.129Z